Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
35.57B | 34.95B | 32.72B | 30.98B | 27.59B | Gross Profit |
12.70B | 11.96B | 10.88B | 10.49B | 9.16B | EBIT |
4.92B | 4.19B | 3.89B | 3.58B | 2.26B | EBITDA |
7.12B | 6.02B | 5.38B | 4.97B | 3.62B | Net Income Common Stockholders |
3.46B | 3.18B | 2.68B | 2.63B | 1.12B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.72B | 6.33B | 5.94B | 5.78B | 7.72B | Total Assets |
50.61B | 47.47B | 45.19B | 44.67B | 44.94B | Total Debt |
15.31B | 13.02B | 10.96B | 12.16B | 13.85B | Net Debt |
11.59B | 6.69B | 5.02B | 6.38B | 6.13B | Total Liabilities |
27.76B | 25.85B | 22.85B | 23.76B | 24.60B | Stockholders Equity |
21.61B | 20.85B | 21.69B | 20.23B | 19.66B |
Cash Flow | Free Cash Flow | |||
2.41B | 3.20B | 2.28B | 2.42B | 2.94B | Operating Cash Flow |
4.99B | 5.02B | 3.80B | 3.98B | 3.94B | Investing Cash Flow |
-6.29B | -2.39B | -917.00M | -2.51B | -1.06B | Financing Cash Flow |
-1.19B | -2.38B | -2.50B | -3.11B | 287.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £66.77B | 19.64 | 16.07% | 1.50% | 1.78% | 15.53% | |
78 Outperform | $35.28B | 38.98 | 12.10% | 0.70% | -2.24% | 3.00% | |
76 Outperform | $7.79B | 16.72 | 33.51% | 0.43% | 0.64% | -1.15% | |
75 Outperform | $32.30B | 16.54 | 11.88% | 0.58% | -0.54% | -48.61% | |
73 Outperform | $7.83B | 8.36 | 6.58% | 1.34% | -8.41% | 570.14% | |
68 Neutral | $10.45B | 24.05 | 21.77% | ― | 1.26% | -17.38% | |
49 Neutral | $1.95B | -1.37 | -21.20% | 3.73% | 0.84% | -29.84% |